ORAL CIPROFLOXACIN AND A MONOCLONAL-ANTIBODY TO LIPOPOLYSACCHARIDE PROTECT LEUKOPENIC RATS FROM LETHAL INFECTION WITH PSEUDOMONAS-AERUGINOSA

被引：31

作者：

COLLINS, HH

CROSS, AS

DOBEK, A

OPAL, SM

MCCLAIN, JB

SADOFF, JC

机构：

[1] WALTER REED ARMY INST RES,DEPT BACTERIAL DIS,WASHINGTON,DC 20307

[2] WALTER REED ARMY MED CTR,DEPT ELECT ENGN,WASHINGTON,DC 20307

来源：

JOURNAL OF INFECTIOUS DISEASES | 1989年 / 159卷 / 06期

关键词：

D O I：

10.1093/infdis/159.6.1073

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：1073 / 1082

页数：10

共 33 条

[1] PHARMACOKINETICS OF ORAL CIPROFLOXACIN, 100 MG SINGLE DOSE, IN VOLUNTEERS AND ELDERLY PATIENTS [J].

BALL, AP ;

FOX, C ;

BALL, ME ;

BROWN, IRF ;

WILLIS, JV .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1986, 17 (05) :629-635

[2] PHARMACOKINETICS OF CIPROFLOXACIN AFTER INTRAVENOUS AND INCREASING ORAL DOSES [J].

BERGAN, T ;

THORSTEINSSON, SB ;

KOLSTAD, IM ;

JOHNSEN, S .

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1986, 5 (02) :187-192

[3] CHANGES IN THE PHARMACOKINETICS OF CIPROFLOXACIN AND FECAL FLORA DURING ADMINISTRATION OF A 7-DAY COURSE TO HUMAN VOLUNTEERS [J].

BRUMFITT, W ;

FRANKLIN, I ;

GRADY, D ;

HAMILTONMILLER, JMT ;

ILIFFE, A .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1984, 26 (05) :757-761

[4] ANTIMICROBIAL ACTIVITY OF CIPROFLOXACIN AGAINST PSEUDOMONAS-AERUGINOSA, ESCHERICHIA-COLI, AND STAPHYLOCOCCUS-AUREUS DETERMINED BY THE KILLING CURVE METHOD - ANTIBIOTIC COMPARISONS AND SYNERGISTIC INTERACTIONS [J].

CHALKLEY, LJ ;

KOORNHOF, HJ .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1985, 28 (02) :331-342

[5] CIPROFLOXACIN, A QUINOLONE CARBOXYLIC-ACID COMPOUND ACTIVE AGAINST AEROBIC AND ANAEROBIC-BACTERIA [J].

CHIN, NX ;

NEU, HC .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1984, 25 (03) :319-326

[6] SYNERGY OF CIPROFLOXACIN AND AZLOCILLIN INVITRO AND IN A NEUTROPENIC MOUSE MODEL OF INFECTION [J].

CHIN, NX ;

JULES, K ;

NEU, HC .

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1986, 5 (01) :23-28

[7] RELEASE OF ENDOTOXIN FROM BACTERIA EXPOSED TO CIPROFLOXACIN AND ITS PREVENTION WITH POLYMYXIN-B [J].

COHEN, J ;

MCCONNELL, JS .

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1986, 5 (01) :13-17

[8]

CROSS A, 1983, REV INFECT DIS, V5, pS837

[9] PHARMACOKINETICS AND TISSUE PENETRATION OF CIPROFLOXACIN [J].

CRUMP, B ;

WISE, R ;

DENT, J .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1983, 24 (05) :784-786

[10] MEMBRANE-PERMEABILITY CHANGES ASSOCIATED WITH DNA GYRASE INHIBITORS IN ESCHERICHIA-COLI [J].

DOUGHERTY, TJ ;

SAUKKONEN, JJ .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1985, 28 (02) :200-206

← 1 2 3 4 →